We are live on ! Find out more
RLYB icon

Rallybio

58 hedge funds and large institutions have $105M invested in Rallybio in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

0.69% less ownership

Funds ownership: 11.01%10.32% (-0.69%)

7% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 14

2% less funds holding

Funds holding: 5958 (-1)

44% less capital invested

Capital invested by funds: $188M → $105M (-$83.1M)

Holders
58
Holders Change
-1
Holders Change %
-1.69%
% of All Funds
0.92%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
5
Increased
13
Reduced
14
Closed
5
Calls
Puts
Net Calls
Net Calls Change

RLYB Hedge Fund Activity: Q3 2023 in Review

58 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Rallybio (RLYB) for Q3 2023, worth a combined $105M — down 44% from $188M a quarter earlier.

Fund positioning in RLYB was balanced in Q3 2023: 5 funds opened new positions, 5 closed out, 13 added to existing stakes and 14 trimmed.

The largest buyer was Bridgeway Capital Management, adding an estimated $347K. The largest seller was Mariner, cutting an estimated $1.07M.

  • 58 institutional investors held Rallybio (RLYB) as of Q3 2023, down from 59 in Q2 2023.
  • Funds reported $105M of Rallybio stock for Q3 2023, down 44% quarter-over-quarter.
  • 5 funds opened new Rallybio positions in Q3 2023 and 5 closed out, a net change of 0 holders.
  • The largest Rallybio buyer in Q3 2023 was Bridgeway Capital Management, an estimated $347K added.
  • The largest Rallybio seller in Q3 2023 was Mariner, an estimated $1.07M sold.

Based on aggregated 13F filings for Q3 2023.